Literature DB >> 9177063

Mortality and survival among a cohort of drug injectors in Glasgow, 1982-1994.

M Frischer1, D Goldberg, M Rahman, L Berney.   

Abstract

There has been much speculation about the nature and extent of mortality among drug injectors in Glasgow. In order to determine injectors' mortality rate and compare this rate to the general population, identifier information from 459 drug injectors who received treatment for drug misuse in Glasgow between 1982 and 1994 was linked to the Scottish Mortality Register. The average duration of follow-up from cohort entry was 5.5 years and 10.2 years from commencement of drug injection. By the end of 1994, 53 cohort members had died. The average annual mortality rate of 1.8% was the same as that observed in a London cohort followed-up from 1969 to 1991. However, the excess mortality ratio (EMR) of 22.0 was almost double the London rate (11.9) because of the much lower average age of mortality (26.3 vs. 38.2 years). There was no significant time trend in EMR. Kaplan-Meier hazard analyzes show that younger patients and those who were HIV positive had significantly elevated mortality rates. The main cause of death was overdose, although it is unclear how many were accidental and how many intentional. Three of the six fatalities among HIV positive injectors were AIDS related. This study enables the first realistic assessment of the hypothesis that drug-related deaths in Glasgow are especially high. In relation to other populations of drug injectors, the annual mortality rate is comparable, although the average age of mortality is much lower in Glasgow. Consequently, in comparison to the general population, the mortality rate of drug injectors is higher in Glasgow compared to other cities.

Entities:  

Mesh:

Year:  1997        PMID: 9177063

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  32 in total

1.  Reducing deaths among drug misusers.

Authors:  M B Gabbay; T Carnwath; C Ford; D A Zador
Journal:  BMJ       Date:  2001-03-31

2.  Primary care groups and research networks: opportunities for R&D in context.

Authors:  P Thomas; J Kai; A O'Dwyer; F Griffiths
Journal:  Br J Gen Pract       Date:  2000-02       Impact factor: 5.386

3.  A cautious welcome for the new guidelines on management of drug dependence.

Authors:  M B Gabbay; T Carnwath
Journal:  Br J Gen Pract       Date:  2000-02       Impact factor: 5.386

4.  Reducing deaths among drug misusers. General Medical Council may be destroying the British system.

Authors:  A S Trebach
Journal:  BMJ       Date:  2001-09-01

5.  Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study.

Authors:  Aumphornpun Buavirat; Kimberly Page-Shafer; G J P van Griensven; J S Mandel; J Evans; J Chuaratanaphong; S Chiamwongpat; R Sacks; A Moss
Journal:  BMJ       Date:  2003-02-08

6.  Policing and risk of overdose mortality in urban neighborhoods.

Authors:  Amy S B Bohnert; Arijit Nandi; Melissa Tracy; Magdalena Cerdá; Kenneth J Tardiff; David Vlahov; Sandro Galea
Journal:  Drug Alcohol Depend       Date:  2010-08-19       Impact factor: 4.492

7.  The epidemiology of hepatitis C in a UK health regional population of 5.12 million.

Authors:  A H Mohsen
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

8.  Do HIV disease progression and HAART response vary among injecting drug users in Europe?

Authors:  Liselotte van Asten; Robert Zangerle; Ildefonso Hernández Aguado; Faroudy Boufassa; Barbara Broers; Raymond P Brettle; J Roy Robertson; Jim McMenamin; Roel A Coutinho; Maria Prins
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

9.  Tobacco, betel quid, alcohol, and illicit drug use among 13- to 35-year-olds in I-Lan, rural Taiwan: prevalence and risk factors.

Authors:  K T Chen; C J Chen; A Fagot-Campagna; K M Narayan
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

10.  No longer only a young man's disease--illicit drugs and older people.

Authors:  I Crome; H Sidhu; P Crome
Journal:  J Nutr Health Aging       Date:  2009-02       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.